TCT 2010 Volcano Investor Event at TCT and Sessions of Interest

related stories:
Intravascular
Imaging Center

Volcano Drives Innovation Forward With Three New U.S. Product Launches at TCT 2010

September 21, 2010 -- San Diego -- Volcano Corporation (NASDAQ: VOLC) will be hosting an investor and analyst event at the upcoming meeting at TCT in Washington, D.C. We plan to conclude the event by 10:45am, so that you can attend 11 a.m. presentations at the conference.

Barry D. Rutherford, MD

The keynote speaker for our investor event will be Dr. Barry Rutherford, a leading interventional cardiologist, who will be discussing the limitations of angiography and that its use alone is not sufficient in the diagnosis and treatment of patients. Dr. Rutherford is director of the Interventional Cardiology Research Program at the Mid America Heart Institute of Saint Luke’s Hospital in Kansas City.

In addition, Scott Huennekens, Volcano’s President and Chief Executive Officer, will provide a brief &A session will follow the formal presentations.

Date: Thursday, September 23
Time: 10:00-10:45 a.m.
Location: Grand Hyatt at Washington Center
1000 H St., N.W.
“Conference Theatre” room, located on level 1B
Additional details on this event and our other activities are forthcoming.

To RSVP, please contact Cindy Birse at cbirse@volcanocorp.com, or (858) 720-4050.

We will be displaying our full product line, including IVUS, FFR, Image-Guided Therapy, Forward-Looking IVUS and OCT at Booth #1517

John Dahldorf, the Company’s Chief Financial Officer, will be available for one-on-one meetings on Thursday, September 23, from 7:30-9:30 a.m., and the balance of the day following our investor event. Please contact Neal Rosen at (415) 692-3058, or rosenn@ruderfinn.com to arrange a meeting.

Also at this year's TCT, Volcano highlights the following sessions of interest:

Tuesday, September 21:
11:42a.m.: “Integrated Multimodality Invasive Imaging and Physiology Concepts: IVUS (Including Forward-Looking) Plus OCT Plus FFR and Others,” Dr. D. Geoffrey Vince, Volcano Corporation, Room 145 AB.

4:27 p.m.: “Implications from PROPSECT and Future Directions,” Dr. Gregg W. Stone, Room 207B.

Wednesday, September 22:
3:30 p.m.: “Intravascular Ultrasound-Guided Drug-Eluting Stent Placement is Associated with Reduced Incidence of Recurrent Clinical Events (Death or MI), Dr. Bimmer Claessen.

4:00 p.m.: “Impact of Intravascular Ultrasound Guidance on 3-Year Clinical Outcomes in Patients Treated with Drug-Eluting Stent for Bifurcation Lesions Data From a Korean Multi-Center Bifurcation Registry,” Dr. Jung-Sun Kim.

Thursday, September 23:
4:55 p.m.: “FFR Changes the Diagnostic Patient Evaluation Paradigm,” Dr. Nico Piljs.

Friday, September 24:
2:00 p.m.: “How to Engage CMS and FDA Collaboratively,” a panel discussion featuring Scott Huennekens of Volcano Corporation.

5:00 p.m.: Physiologic Assessment Should Guide Routine PCI Therapy and Minimize Unnecessary Stents,” Dr. Nico Piljs.

Saturday, September 25:
12:15 p.m.: “Top TCT 2010 Lessons: Cardiovascular Imaging,” a panel moderated by Dr. Gary Mintz.

Source: Volcano Corporation